STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Clinical trials for STAGE III PROSTATE ADENOCARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PROSTATE ADENOCARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III PROSTATE ADENOCARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise in slowing prostate cancer spread
Disease control CompletedThis study looked at whether adding the drug axitinib to standard hormone therapy before surgery could help control prostate cancer that has spread to lymph nodes. 73 men with previously untreated prostate cancer took part. The goal was to see if the combination could delay cance…
Matched conditions: STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:52 UTC
-
Can adding chemo to standard therapy prevent prostate cancer return?
Disease control CompletedThis study looked at 612 men with prostate cancer who had their prostate removed. It compared standard treatment (radiation plus hormone therapy) to the same treatment plus a chemotherapy drug called docetaxel. The goal was to see if adding chemo helps keep cancer from coming bac…
Matched conditions: STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 26, 2026 06:45 UTC
-
Can fewer radiation sessions improve life after prostate surgery?
Symptom relief CompletedThis study tested whether a shorter course of higher-dose radiation (hypofractionated) is better than the usual longer course of radiation for men who had prostate cancer surgery. About 296 men took part. The main goal was to see how each approach affects urinary and bowel qualit…
Matched conditions: STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 26, 2026 07:02 UTC